Diversified Consumer Services
Company Overview of Yale University
Yale University is an independent research and educational institution that offers programs, departments, schools, centers, museums, and affiliated organizations. The university offers graduate and professional courses in art, architecture, divinity, drama, engineering, music, forestry and environmental studies, law, management, and medicine. Yale University was founded in 1701 and is based in New Haven, Connecticut.
206 Elm Street
New Haven, CT 06511-9992
Founded in 1701
Key Executives for Yale University
Vice President of New Haven and State Affairs
Vice President for Finance & Business Operations
Program Director of Center for Business and the Environment
Vice President for Global and Strategic Initiatives
Compensation as of Fiscal Year 2014.
Yale University Key Developments
Amway Extends its Exclusive Research Partnership with Yale University Through 2016
May 27 14
Amway has extended its exclusive research partnership with Yale University through 2016, adding an additional three years to the original agreement. Doubling the length of this collaboration enables Amway scientists and Yale Lab Associate and Research Faculty Member Dr. John Pawelek to continue advancing their collective understanding of the molecular biology involved in skin pigmentation -- specifically hyperpigmented spots. Understanding the pathways involved enables the development of more effective, more targeted treatments. Findings will fuel breakthrough products in the Artistry Ideal Radiance(TM) Collection targeting skin brightening. Shown to have psychological and emotional impacts, hyperpigmented disorders are the result of highly increased melanin, the pigment responsible for producing color in hair, skin and eyes. In some cases, melanin is located in spots like solar lentigenes (age spots) and post-inflammatory hyperpigmentation (PIH) and in others, it covers larger regions of skin, as in melasma. Topical treatments assume all disorders are equal and respond to treatment as such. However, clinician success requires individualized diagnosis and treatment. PIH and melasma have a relatively high improvement rate, whereas solar lentigenes (age spots) are much more difficult to treat. This new research will seek to understand these solar lentigenes (age spots) and develop models that predict more successful treatments, ultimately translating into targeted products that improve consumer satisfaction.
Debiopharm Group Signs New License and Research Agreement with Yale University
May 9 14
Debiopharm Group has signed a new license and research agreement with Yale University. The agreement has been signed to discover MIF inhibitors for the treatment of autoimmune and inflammatory diseases. It will allow the discovery and development of potential oral first-in-class compounds that inhibit Macrophage Migration Inhibitory Factor, a major regulatory cytokine that has been linked genetically to the pathogenesis of several autoimmune and inflammatory diseases.
Yale University Presents at World Congress on Industrial Biotechnology, May-12-2014
May 9 14
Yale University Presents at World Congress on Industrial Biotechnology, May-12-2014 . Venue: Philadelphia, Pennsylvania, United States.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|